Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.24.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Dec. 28, 2024
Dec. 30, 2023
Dec. 31, 2022
Statement of Cash Flows [Abstract]      
Cash and cash equivalents, beginning of period $ 7,079 $ 11,144 $ 4,827
Cash flows provided by (used for) operating activities:      
Net income (loss) (19,233) 1,675 8,017
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 9,951 7,847 11,128
Share-based compensation 3,410 3,229 3,128
Restructuring and other charges 3,491 (424) 1,074
Amortization of intangibles 1,428 1,755 1,907
(Gains) losses on equity investments, net (246) (42) (4,254)
(Gains) losses on divestitures 0 0 (1,059)
Deferred taxes 6,132 (2,033) (5,148)
Impairments and net (gain) loss on retirement of property, plant, and equipment 2,252 33 301
Changes in assets and liabilities:      
Accounts receivable (75) 731 5,327
Inventories (1,105) 2,097 (2,436)
Accounts payable 634 (801) (29)
Accrued compensation and benefits (218) (614) (1,533)
Income taxes (356) (1,498) 613
Other assets and liabilities 2,223 (484) (1,603)
Total adjustments 27,521 9,796 7,416
Net cash provided by (used for) operating activities 8,288 11,471 15,433
Cash flows provided by (used for) investing activities:      
Additions to property, plant, and equipment (23,944) (25,750) (24,844)
Proceeds from capital-related government incentives 1,936 1,011 246
Acquisitions, net of cash acquired (82) (13) (681)
Purchases of short-term investments (37,940) (44,414) (43,647)
Maturities and sales of short-term investments 41,463 44,077 48,730
Sales of equity investments 1,047 472 4,961
Proceeds from divestitures 0 0 6,579
Other investing (736) 576 (1,575)
Net cash provided by (used for) investing activities (18,256) (24,041) (10,231)
Cash flows provided by (used for) financing activities:      
Issuance of commercial paper, net of issuance costs 7,349 0 3,945
Repayment of commercial paper (7,349) (3,944) 0
Partner contributions 12,714 1,511 874
Proceeds from sales of subsidiary shares 0 2,959 1,032
Additions to property, plant, and equipment (1,178) 0 0
Issuance of long-term debt, net of issuance costs 2,975 11,391 6,548
Repayments of Long-term Debt (2,288) (423) (4,984)
Proceeds from sales of common stock through employee equity incentive plans 987 1,042 977
Restricted stock unit withholdings (631) (534) (486)
Payment of dividends to stockholders (1,599) (3,088) (5,997)
Other financing 158 (409) (794)
Net cash provided by (used for) financing activities 11,138 8,505 1,115
Net increase (decrease) in cash and cash equivalents 1,170 (4,065) 6,317
Cash and cash equivalents, end of period 8,249 7,079 11,144
Non-cash supplemental disclosures:      
Acquisition of property, plant, and equipment 8,125 4,804 5,431
Interest, net of capitalized interest 987 613 459
Income taxes, net of refunds $ 2,202 $ 2,621 $ 4,282